The highest per capita sales of hypnotic and sedative medicines in 2023 were seen in Iceland (15.5 USD), followed by Norway (7.4 USD). Czech Republic (4 USD) and Chile (3.5 USD) showed moderate per capita sales. Slow growth was noted in markets like Slovakia (2.7 USD), Spain (2.2 USD), and Italy (0.4 USD). Year-on-year variations in 2023 highlight significant growth in Chile (13%) and Norway (7.31%), while stable to moderate gains were recorded in Iceland (6.15%), Italy (5.92%), Slovakia (3.26%), Spain (2.98%), and Czech Republic (2.13%).
Future trends to monitor include:
- The impact of demographic changes on demand, particularly in aging populations.
- Regulatory shifts influencing availability and sales patterns across Europe and South America.
- Potential market saturation in high-sales countries like Iceland and Norway and potential opportunities in underpenetrated markets like Italy.
Top countries in Hypnotic and Sedative Medicine Sales by Country
| # | 7 Countries | US Dollars PPP Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Iceland | 15.5 | 2023 | +1.31% | +6.15% | View data |
| 2 | 2 Norway | 7.4 | 2023 | +15.63% | +7.31% | View data |
| 3 | 3 Czech Republic | 4 | 2023 | +25% | +2.13% | View data |
| 4 | 4 Chile | 3.5 | 2023 | +2.94% | +13% | View data |
| 5 | 5 Slovakia | 2.7 | 2023 | +3.85% | +3.26% | View data |
| 6 | 6 Spain | 2.2 | 2023 | +4.76% | +2.98% | View data |
| 7 | 7 Italy | 0.4 | 2023 | +100% | +5.92% | View data |
